188 related articles for article (PubMed ID: 21985851)
1. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.
Zhang QL; Tian DA; Xu XJ
Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851
[TBL] [Abstract][Full Text] [Related]
2. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.
Zhu X; Dai Y; Chen Z; Xie J; Zeng W; Lin Y
Oncol Res; 2013; 20(8):377-81. PubMed ID: 23924858
[TBL] [Abstract][Full Text] [Related]
4. Expression of zinc finger 23 gene in human hepatocellular carcinoma.
Shi Y; Zheng L; Luo G; Wei J; Zhang J; Yu Y; Feng Y; Li M; Xu N
Anticancer Res; 2011 Oct; 31(10):3595-9. PubMed ID: 21965783
[TBL] [Abstract][Full Text] [Related]
5. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
7. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
Jin XL; Sun QS; Liu F; Yang HW; Liu M; Liu HX; Xu W; Jiang YY
J Cell Biochem; 2013 Jul; 114(7):1625-33. PubMed ID: 23355454
[TBL] [Abstract][Full Text] [Related]
8. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB
Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
[TBL] [Abstract][Full Text] [Related]
15. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
16. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
Fang F; Yang L; Tao Y; Qin W
Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761
[TBL] [Abstract][Full Text] [Related]
17. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
18. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
19. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]